Miniaturized antibody of anti-glucocorticoid-induced tumor necrosis factor receptor (GITR), and polymer and use thereof
US11708417B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Mar 26, 2019 |
| Grant date | Jul 25, 2023 |
| Priority date | — |
| Expiry date | Feb 28, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/715
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An antibody that specifically binds to a glucocorticoid-induced tumor necrosis factor receptor (GITR), an antibody fragment and a polymer thereof, and a conjugate and a fusion comprising the antibody or the antibody fragment are provided in the present invention. A nucleic acid encoding the antibody, the antibody fragment, the polymer, the conjugate and the fusion, a vector, and a host cell expressing the nucleic acid are also provided in the present invention. In addition, a composition comprising the antibody and the antibody fragment thereof, the polymer, the conjugate or the fusion, and use thereof in therapy and diagnosis are also provided in the present invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.